Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cysteine desulfurase (NFS1) is a critical pyridoxal-phosphate-dependent enzyme that catalyzes the conversion of L-cysteine to L-alanine and a sulfur-containing persulfide intermediate [11, 19]. This enzyme serves as the primary sulfur donor for the biogenesis of iron-sulfur (Fe-S) clusters, which are indispensable cofactors for dozens of proteins involved in cellular respiration, DNA repair, and iron homeostasis [6, 17]. In the context of oncology, NFS1 is recognized as a key therapeutic target because its overexpression in certain cancers, particularly lung adenocarcinoma and gastric cancer, protects cells from oxidative stress and ferroptosis by maintaining Fe-S cluster integrity in high-oxygen environments [4, 10, 20]. Therapeutic strategies currently under investigation include the use of selective small-molecule inhibitors like Compound 53 and inhibitory decoy substrates such as D-cysteine to sensitize tumors to ferroptotic cell death [1, 5, 13]. However, as NFS1 is a vital housekeeping enzyme, developing these therapies requires careful management of potential toxicities associated with the disruption of essential mitochondrial functions in healthy tissues [6, 20].
Selective inhibition of enzymatic activity or acting as a decoy substrate to disrupt sulfur mobilization, thereby impairing iron-sulfur cluster biogenesis and inducing ferroptosis [1, 2, 20].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cysteine desulfurase (NFS1) (NFS1).